Loading search results

Outcome Measures

Primary Outcomes (1)

Cognitive functioning as measured by Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) (English)
The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) comprises auditory and visual subtasks of attention, language, visuospatial/constructional abilities, and immediate and delayed memory. Each subtask is assessed as accuracy (number of correct responses) and subsequently combined into a composite score (RBANS Total Scale score).
Once, 6 months to 36 months post-discharge from the hospital.

Secondary Outcomes (11)

Executive functioning as measured by the Oral Trail Making Test-B (OTMT-B; English)
Once, 6 months to 36 months post-discharge from the hospital.
Cognitive control as measured by the Stroop test (English)
Once, 6 months to 36 months post-discharge from the hospital.
Verbal intellectual ability as measured by the National Adult Reading Test (NART) for English speakers and the Word Accentuation Test (WAT).
Once, 6 months to 36 months post-discharge from the hospital.
Verbal Fluency (English)
Once, 6 months to 36 months post-discharge from the hospital.
Mood symptoms as assessed by DASS (English)
Once, 6 months to 36 months post-discharge from the hospital.
+6 more secondary outcomes

Study Arms (2)

COVID-19 group

COVID-19 group will be made up of 30 patients that have a past diagnosis of COVID-19 with confirmed positive SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) PCR (polymerase chain reaction) test in their electronic medical record and were previously hospitalized at NYP/WCM (NewYork Presbyterian/ Weill Cornell Medicine) between March 1 and December 31, 2020 for a minimum of three days. Administration of study instruments, including self-report measures of mood, anxiety, post-traumatic stress and adjustment, and objective neuropsychological tests of cognitive function will be done via telephone interview, videoconference interview, and/or Redcap survey for both groups.

Comparison group

The subjects in comparison group will be 30 patients previously hospitalized at NYP/WCM between March 1 and December 31, 2020 for a minimum of three days. The recruited subjects would have undergone hospitalization secondary to a medical diagnosis that was not COVID-19. Administration of study instruments, including self-report measures of mood, anxiety, post-traumatic stress and adjustment, and objective neuropsychological tests of cognitive function will be done via telephone interview, videoconference interview, and/or Redcap survey for both groups.

Eligibility Criteria

Age18 Years - 89 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

60 patients who were previously hospitalized at NYP/WCM between March 1 and December 31, 2020 for a minimum of three days will be enrolled. Out of 60, 30 patients would have a past diagnosis of COVID-19 and 30 patients would have undergone hospitalization secondary to a medical diagnosis that was not COVID-19.

You may qualify if:

Men and women age 18-89.

MeSH Terms

Conditions

COVID-19Anxiety DisordersCognitive Dysfunction

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesMental Disorders

Study Stopped

COVID-19 (Coronavirus Disease-2019) Psychiatric Outcomes

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (11)

Study Arms (2)

COVID-19 group

Comparison group

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (11)

Study Arms (2)

COVID-19 group

Comparison group

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations